Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000167099 | SCV000217929 | likely benign | Hereditary cancer-predisposing syndrome | 2014-12-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000167099 | SCV001358993 | likely benign | Hereditary cancer-predisposing syndrome | 2020-03-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001456175 | SCV001659952 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2023-07-28 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004806147 | SCV005429111 | likely benign | Lynch syndrome | 2024-07-29 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV005246747 | SCV005898443 | benign | Lynch syndrome 1 | 2024-12-09 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Department of Pathology and Laboratory Medicine, |
RCV005361031 | SCV005921052 | likely benign | Lynch syndrome 1; Muir-Torré syndrome; Mismatch repair cancer syndrome 2 | 2021-03-02 | criteria provided, single submitter | clinical testing |